0JZU Stock Overview
Provides healthcare services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
McKesson Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$631.30 |
| 52 Week High | US$636.44 |
| 52 Week Low | US$431.28 |
| Beta | 0.44 |
| 11 Month Change | 24.20% |
| 3 Month Change | 12.87% |
| 1 Year Change | 37.63% |
| 33 Year Change | 188.56% |
| 5 Year Change | 346.84% |
| Change since IPO | 257.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0JZU | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 1.8% | -0.3% | 2.2% |
| 1Y | 37.6% | -22.7% | 9.0% |
Return vs Industry: 0JZU exceeded the UK Healthcare industry which returned -23.5% over the past year.
Return vs Market: 0JZU exceeded the UK Market which returned 8.4% over the past year.
Price Volatility
| 0JZU volatility | |
|---|---|
| 0JZU Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0JZU has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0JZU's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
McKesson Corporation Fundamentals Summary
| 0JZU fundamental statistics | |
|---|---|
| Market cap | US$79.34b |
| Earnings (TTM) | US$2.54b |
| Revenue (TTM) | US$330.19b |
31.4x
P/E Ratio0.2x
P/S RatioIs 0JZU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0JZU income statement (TTM) | |
|---|---|
| Revenue | US$330.19b |
| Cost of Revenue | US$317.29b |
| Gross Profit | US$12.89b |
| Other Expenses | US$10.36b |
| Earnings | US$2.54b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.98 |
| Gross Margin | 3.90% |
| Net Profit Margin | 0.77% |
| Debt/Equity Ratio | -208.9% |
How did 0JZU perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield13%
Payout RatioDoes 0JZU pay a reliable dividends?
See 0JZU dividend history and benchmarks| McKesson dividend dates | |
|---|---|
| Ex Dividend Date | Dec 02 2024 |
| Dividend Pay Date | Jan 02 2025 |
| Days until Ex dividend | 4 days |
| Days until Dividend pay date | 35 days |
Does 0JZU pay a reliable dividends?
See 0JZU dividend history and benchmarks